Cloud Pharmaceuticals
Southeastern
About Cloud Pharmaceuticals
Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. We use a proprietary design process that combines artificial intelligence (AI) and cloud computing to search virtual molecular space and applies along sophisticated molecular modeling to design novel drugs that are well-qualified for development from the outset and have original composition of matter IP. The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications. Our approach amplifies the power of cloud computing and AI to radically improve drug discovery and design. We partner at all stages of drug development – from discovery through the clinic – and are building an extensive product pipeline that spans a wide range of indications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $1.8M
- Last round: Series Unknown (Feb 2016)
- Website: cloudpharmaceuticals.com
- Phone: 910.398.1200
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cloud-pharmaceuticals-108587 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.